Company name: Chemi Pharmaceutical
Description: Provider of laboratory services for testing cannabis based in Ontario, Canada. The company specializes in pharmaceutical, veterinary, natural health products analysis and development and validation of analytical methods.
Year founded: 2001
Industry: Healthcare | Group: | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (no backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company is in talks to be acquired by Aurora Cannabis Inc (NYE:ACB) for $750,000 on April 25, 2019. The company’s shareholders will receive 83,299 shares on closing. Additionally, 41,649 shares will be paid upon the achievement of certain milestones by the company. The integration will allow Aurora Cannabis Inc ‘s subsidiary to expand its analytics capabilities to meet client demands and diversify its testing services.
Number of active investors:
Profile last updated: 30-Apr-2019
Last known valuation: 0.75
Last known valuation date: 25-Oct-2019